For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.
Regulatory context
Regulatory context; not efficacy evidence
No matched controlled clinical study of this exact preparation was verified in this source audit.
Reported findings. Background context only. Matched evidence for the exact marketed formulation is not established by this reference.
Nonresponse. Nonresponse frequency not established in this excerpt.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. Related-compound evidence is contextual only. Commercial names, modifications and routes do not establish clinical equivalence.
Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.
Human report
Public N-Acetyl-Semax-Amidate Acetate experience: original post
One anonymous public account; self-report, not clinician-documented outcome.
Reported findings. No noticeable beneficial effects reported during the three days described.
Nonresponse. Three days without noticeable effects in this one account; later response was not established.
Harms. Brief headache sensation while drinking coffee on the second day; causal attribution unresolved.
Limits. Coffee was used on the second day; the author described avoiding caffeine on the other two days. There was no controlled comparison. Recent Bromantane use was mentioned as preceding context. Plain Semax was still incoming and had not yet been tried in this report; its effects cannot be assigned to this modified compound. One anonymous self-report cannot establish a population response rate, long-term ineffectiveness or a recommendation to change exposure. Exact original creation/edit timestamps remain unknown; cached browser review is separate from the blocked raw check.
Preparation: Vendor-labelled N-Acetyl-Semax-Amidate Acetate; chemical composition/preparation equivalence unverified. Route: Author reports nasal spray; no route inherited by other reports.
Read original source ↗Editorial review 2026-10-15. Clinician review pending.
Human report
Public N-Acetyl-Semax-Amidate experience: distinct comment
Different visible anonymous account from parent-post author; actual person identity unverified.
Reported findings. Immediate perceived improvement in mood, motivation and presence in the moment reported.
Nonresponse. Later duration and nonresponse were not established in this comment.
Harms. Brain fog and some anxiety also reported; causal attribution unresolved.
Limits. A different visible account supports a separate report group, not verification of a distinct person or a controlled comparison. The commenter refers to the same named modified substance; the parent post's nasal route and coffee use are not inherited. Route, co-interventions and exact creation/edit timestamps remain unknown. This comment is not evidence about unmodified Semax or other acetylated/amidated identities. Anonymous reports do not supply a population response rate. Cached browser editorial review is separate from the original-URL raw request that returned HTTP 403.
Preparation: Vendor-labelled N-Acetyl-Semax-Amidate Acetate; chemical composition/preparation equivalence unverified. Route: Not stated in comment; parent-post nasal route not inherited.
Read original source ↗Editorial review 2026-10-15. Clinician review pending.